Madison Avenue Partners, LP Theravance Biopharma, Inc. Transaction History
Madison Avenue Partners, LP
- $626 Million
- Q4 2024
A detailed history of Madison Avenue Partners, LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 9,511,150 shares of TBPH stock, worth $88.9 Million. This represents 14.29% of its overall portfolio holdings.
Number of Shares
9,511,150
Previous 9,511,150
-0.0%
Holding current value
$88.9 Million
Previous $76.7 Million
16.75%
% of portfolio
14.29%
Previous 9.44%
Shares
6 transactions
Others Institutions Holding TBPH
# of Institutions
129Shares Held
46.5MCall Options Held
600Put Options Held
300-
Weiss Asset Management LP Boston, MA7.46MShares$69.7 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$44.5 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$35.3 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.8 Million2.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$18.8 Million0.0% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $624M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...